PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10535965-8	1999	Finally, we show that treatment of BAEC with bradykinin causes a significant increase in cellular ceramide content; the response to bradykinin has an EC(50) of 3 nM and is blocked by the bradykinin B(2)-receptor antagonist HOE140.	baec	35-39	kininogen 1	Bos taurus	45-55	
10899167-5	2000	Within minutes of adding bradykinin to BAEC, the eNOS-Raf-1-ERK-Akt heteromeric complex dissociated, and it subsequently reassociated following more prolonged agonist stimulation.	baec	39-43	kininogen 1	Bos taurus	25-35	
10899167-6	2000	Bradykinin treatment of BAEC led to the activation of ERK, associated with an increase in phosphorylation of eNOS; phosphorylation of eNOS by ERK in vitro significantly reduced eNOS enzyme activity.	baec	24-28	kininogen 1	Bos taurus	0-10	
10535965-8	1999	Finally, we show that treatment of BAEC with bradykinin causes a significant increase in cellular ceramide content; the response to bradykinin has an EC(50) of 3 nM and is blocked by the bradykinin B(2)-receptor antagonist HOE140.	baec	35-39	kininogen 1	Bos taurus	132-142	
10535965-8	1999	Finally, we show that treatment of BAEC with bradykinin causes a significant increase in cellular ceramide content; the response to bradykinin has an EC(50) of 3 nM and is blocked by the bradykinin B(2)-receptor antagonist HOE140.	baec	35-39	kininogen 1	Bos taurus	132-142	
7509258-9	1994	Pretreatment of BAEC with palmitoyl-L-carnitine (5-10 microM) inhibited bradykinin induced Ca2+ transients.	baec	16-20	kininogen 1	Bos taurus	72-82	
9242963-6	1997	Results demonstrate that increasing concentrations of HCY, and not cysteine or glutathione, in the presence of bradykinin at 0.5, 1, and 4 h led to significant (P < 0.05 by ANOVA) time- and dose-dependent increases in RSNO produced by BAEC.	baec	238-242	kininogen 1	Bos taurus	111-121	
9223444-4	1997	Exposure of BAEC to the eNOS-activating agonists, BK, histamine, or ATP produces transient increases in the amounts of detergent-insoluble caveolin-1.	baec	12-16	kininogen 1	Bos taurus	50-52	
1665733-4	1991	Pretreatment of BAEC with 4 beta-phorbol 12-myristate 13-acetate (PMA; 100 nM) reduced the magnitude of the initial transient elevation of [Ca2+]i, induced by thrombin (1 mu ml-1), low concentrations of bradykinin (1 nM) or ATP (0.3 microM, 3 microM), but not by higher concentrations of the latter two agonists.	baec	16-20	kininogen 1	Bos taurus	203-213	
8282000-5	1993	Preincubation of BAEC with CTx, but not with PTx, inhibited bradykinin-dependent production of cyclic GMP.	baec	17-21	kininogen 1	Bos taurus	60-70	
8100285-14	1993	Similarly, the cGMP increase in MC coincubated with BAEC under bradykinin stimulation was not altered by culturing under high glucose or hypertonic conditions.	baec	52-56	kininogen 1	Bos taurus	63-73	
2561988-13	1989	These data indicate action of phospholipase C (PLC) on PIP2 after BK stimulation of BAEC with the subsequent production of InsP3 causing the resulting intracellular Ca2+ release.	baec	84-88	kininogen 1	Bos taurus	66-68	
2388254-7	1990	Efflux of 86Rb+ from BAEC monolayers was stimulated by both bradykinin and ionomycin.	baec	21-25	kininogen 1	Bos taurus	60-70